JPRN-UMIN000049328已完成Unknown
A confirmation study for effects of synbiotics on reducing body fat: A randomized, double-blind, placebo-controlled parallel group study - A confirmation study for effects of synbiotics on reducing body fat
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
Participants consumed a test beverage containing 1 * 10^10 colony-forming units of Bifidobacterium animalis subsp. lactis GCL2505 per 100 g and 2.0 g of inulin per 100 g for 12 weeks. There were significant reductions in visceral fat area and total fat area. The intervention significantly increased the total number of bifidobacteria and affected the levels of several lipid markers.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Subjects who regularly undertake medications that affect obesity, hyperlipidemia or lipid metabolism 2)Subjects who have a history of severe kidney disease, heart disease, respiratory disease, endocrine disease, diabetes, etc., and undergoing treatment for them (excluding transient treatment such as colds) 3)Subjects who cannot stop taking health foods or supplements that affect obesity, hyperlipidemia or lipid metabolism 4)Subjects who can't limit the ingestion of foods which may affect intestinal microbiota 5)Subjects who are taking antibiotics and/or anti-microbe agents, or who had taken them within one month prior to the screening test 6)Subjects who regularly use intestinal drugs and laxatives (including strong laxatives) 7)Subjects with a digestive organ disease or surgical history that has an influence on digestive absorption 8)Subjects who declare some allergies to the components of the test product 9)Subjects who has a current or history of drug dependence and/or alcoholism 10)Subjects who have metal in the CT scan measurement site due to surgery, etc. 11) Subjects with implantable medical devices such as cardiac pacemakers and implantable cardioverter-defibrillators 12) Claustrophobic 13)Subject who is pregnant or under lactation, or who is expected to be pregnant during the study 14) Subjects who are currently participating in other clinical studies that take or apply other foods, pharmaceuticals, cosmetics, or chemicals, who have participated in other clinical studies within the past three months from the date of consent, or who plan to participate in others 15) Subjects who are judged unsuitable for this study by principal investigator
研究者
相似试验
已完成
不适用
A study to investigate effects of Probiotics (Bifidobacteria) ingestion on visceral fat area in overweight adult: a randomized, double blind, placebo controlled study.oneJPRN-UMIN000023919KSO Corporation80
已完成
不适用
Clinical Trial on the Effects of Bifidobacterium Infantis in Active Celiac DiseaseCeliac DiseaseNCT01257620Bai, Julio M.D.22
进行中（未招募）
不适用
Food Trial Evaluating the Efficacy of SBD111 Versus Placebo for the Clinical Dietary Management of the Metabolic Processes of OsteopeniaOsteopeniaNCT05009875Solarea Bio, Inc286
招募中
不适用
Evaluating the Effects of a Synbiotic Versus Probiotic or Placebo on Gut Microbiota and Cardiometabolic Health: A Randomized Double-Blind Placebo Controlled TrialBlood Pressure, Body Composition, Immune FunctionNCT06544915Skidmore College60
已完成
不适用
Verification of improvement effect for insulin sensitivityJPRN-UMIN000033364CPCC Company Limited120